Skip navigation

Enhance Process and System Interoperability to Optimize Data Quality, Improve Trial Efficiency and Ensure Compliance

November 2-3, 2017
  • Philadelphia, PA

Nithiya Ananthakrishnan
CEO
Algorics

Jennifer Bush
Director, Life Sciences Product Strategy
Oracle Health Sciences Global Business Unit

Lynne Brophy
Senior CRA
Esperion

Lynne Cesario
Director, Risk Based Monitoring Program Lead
Pfizer Inc

Lori Convy
Director, Strategic Monitoring
Medidata

Megan DiGregorio-Fecteau
Director, Central Monitoring North America
PRA Health Sciences

Jeannett Dimsits
Senior Director Trial Management Anchor
Novo Nordisk A/S

Joseph Gotowko
Assistant Director,
Quality Systems – Quality Risk Management (QRM)
AbbVie

Jonathan Helfgott
Former Associate Director, Risk Science,
Intelligence & Prioritization, FDA;
Coordinator, Regulatory Science Program, Johns Hopkins University

Andy Lawton
Consultant
Risk Based Approach Ltd.

Suzanne Lukac
Director, Risk-Based Monitoring Implementation
Merck

Kristin Mauri
Global Head, Risk Based Monitoring
Bioclinica

Jules T. Mitchel, PhD
President
Target Health

Brian Nugent
Executive Director Clinical Solutions and Compliance
Ultragenyx Pharmaceutical

Stephen Potter
Director Quality Risk Management
Pfizer Inc

Elizabeth Robinson, RN, MSHS
Executive Director, Clinical Compliance and Operations
Horizon Pharma

Susanne Witzke
Competency Development Specialist, Trial Management Anchor
Novo Nordisk A/S

Steve Young
Chief Operations Officer
CluePoints

Vanesa Castillo
Senior Director Monitoring & Data Flow Optimization
Covance

Nithiya Ananthakrishnan
CEO
Algorics

Jennifer Bush
Director, Life Sciences Product Strategy
Oracle Health Sciences Global Business Unit

Lynne Brophy
Senior CRA
Esperion

Lynne Cesario
Director, Risk Based Monitoring Program Lead
Pfizer Inc

Lori Convy
Director, Strategic Monitoring
Medidata

Megan DiGregorio-Fecteau
Director, Central Monitoring North America
PRA Health Sciences

Jeannett Dimsits
Senior Director Trial Management Anchor
Novo Nordisk A/S

Joseph Gotowko
Assistant Director,
Quality Systems – Quality Risk Management (QRM)
AbbVie

Jonathan Helfgott
Former Associate Director, Risk Science,
Intelligence & Prioritization, FDA;
Coordinator, Regulatory Science Program, Johns Hopkins University

Andy Lawton
Consultant
Risk Based Approach Ltd.

Suzanne Lukac
Director, Risk-Based Monitoring Implementation
Merck

Kristin Mauri
Global Head, Risk Based Monitoring
Bioclinica

Jules T. Mitchel, PhD
President
Target Health

Brian Nugent
Executive Director Clinical Solutions and Compliance
Ultragenyx Pharmaceutical

Stephen Potter
Director Quality Risk Management
Pfizer Inc

Elizabeth Robinson, RN, MSHS
Executive Director, Clinical Compliance and Operations
Horizon Pharma

Susanne Witzke
Competency Development Specialist, Trial Management Anchor
Novo Nordisk A/S

Steve Young
Chief Operations Officer
CluePoints

Vanesa Castillo
Senior Director Monitoring & Data Flow Optimization
Covance